首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1642919

血糖试纸市场 - 全球产业规模、份额、趋势、机会和预测，按类型、最终用户、地区和竞争细分，2020-2030F

Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End-User, By Region and Competition, 2020-2030F

出版日期: 2025年01月24日 | 出版商:

TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024年全球血糖试纸市场估值为105.3亿美元，预计2030年将达134.8亿美元，预测期内复合年增长率为4.40%。在糖尿病盛行率上升、医疗保健技术进步以及对血糖水平自我监测的日益重视的推动下，全球血糖试纸市场正在显着扩张。这些试纸与血糖仪一起使用，透过实现有效的血糖监测，在管理和控製糖尿病方面发挥着至关重要的作用。该市场由持续的技术创新所定义，这些创新导致了更准确和用户友好的测试条的创建。人们对定期血糖监测重要性的认识不断提高，加上糖尿病人口不断增加，进一步推动了对这些产品的需求。推动市场成长的关键因素是糖尿病发病率的上升，这是受到久坐生活方式、不良饮食习惯和全球人口老化的影响。随着糖尿病成为一个广泛的全球健康问题，对可靠的血糖监测设备（包括试纸）的需求持续成长。此外，由于非处方试纸的可近性和便利性，人们已经转向家庭监测。这项转变使糖尿病患者能够更好地控制自己的健康，进一步促进市场成长。

市场概况
预测期	2026-2030
2024 年市场规模	105.3亿美元
2030 年市场规模	134.8亿美元
2025-2030 年复合年增长率	4.40%
成长最快的细分市场	厚膜电化学薄膜
最大的市场	北美洲

然而，儘管取得了这些进步，血糖试纸的成本在一些地区仍然是一个障碍，限制了需要频繁检测的患者的使用。这在低收入地区或医疗保健系统不发达的国家尤其具有挑战性。该市场还受到不同地区严格的监管要求，这可能会延迟产品上市并增加製造成本。目前，北美和欧洲由于医疗基础设施健全、医疗支出高以及糖尿病人口众多，在血糖试纸市场占据主导地位。然而，由于糖尿病发病率上升、医疗保健机会的改善以及中国和印度等国家经济状况的改善，亚太地区预计将经历最快的成长。

在糖尿病盛行率不断上升、技术进步和自我监测转变的推动下，全球血糖试纸市场可望持续成长。市场上的公司需要专注于负担能力、技术创新和教育，以满足全球糖尿病患者不断变化的需求。

主要市场驱动因素

糖尿病发生率上升

对糖尿病管理的认识与关注不断增强

血糖监测设备的技术进步

主要市场挑战

血糖试纸的费用

标准化和合规性

主要市场趋势

将智慧技术整合到监控设备中

家庭血糖监测

细分市场洞察

类型洞察

最终使用者见解

区域洞察

Global Blood Glucose Test Strips Market was valued at USD 10.53 Billion in 2024 and is expected to reach USD 13.48 Billion by 2030 with a CAGR of 4.40% during the forecast period. The global blood glucose test strips market is experiencing notable expansion, fueled by the rising prevalence of diabetes, advancements in healthcare technology, and a growing emphasis on self-monitoring of blood sugar levels. These test strips, which are used alongside glucose meters, play a crucial role in managing and controlling diabetes by enabling effective blood sugar monitoring. The market is defined by ongoing technological innovations that lead to the creation of more accurate and user-friendly test strips. Rising awareness about the significance of regular glucose monitoring, combined with the expanding diabetic population, has further driven demand for these products. A key factor contributing to the market's growth is the increasing incidence of diabetes, which is being influenced by sedentary lifestyles, poor dietary habits, and an aging global population. As diabetes becomes a widespread global health issue, the demand for dependable blood glucose monitoring devices, including test strips, continues to rise. Additionally, there has been a shift toward home-based monitoring due to the accessibility and convenience of over-the-counter test strips. This shift has empowered diabetic individuals to take greater control over their health, further boosting market growth.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 10.53 Billion
Market Size 2030	USD 13.48 Billion
CAGR 2025-2030	4.40%
Fastest Growing Segment	Thick Film Electrochemical Films
Largest Market	North America

However, despite these advancements, the cost of blood glucose test strips remains a barrier in some regions, limiting access for patients who need frequent testing. This is especially challenging in low-income areas or countries with underdeveloped healthcare systems. The market is also subject to strict regulatory requirements across different regions, which can delay product launches and increase manufacturing costs. Currently, North America and Europe dominate the blood glucose test strips market due to their robust healthcare infrastructure, high healthcare expenditures, and large diabetic populations. However, the Asia-Pacific region is expected to experience the fastest growth, driven by a rising incidence of diabetes, improved access to healthcare, and growing economic conditions in countries like China and India.

The global blood glucose test strips market is poised for continued growth, driven by the increasing prevalence of diabetes, technological advancements, and a shift toward self-monitoring. Companies in the market will need to focus on affordability, technological innovation, and education to meet the evolving needs of diabetic patients worldwide.

Key Market Drivers

Rising Incidence of Diabetes

The increasing global prevalence of diabetes is a key driver behind the rapid growth of the Global Blood Glucose Test Strips Market. Diabetes, marked by high blood glucose levels, has reached epidemic proportions, affecting millions worldwide. According to the International Diabetes Federation (IDF) Diabetes Atlas (2021), 10.5% of the adult population (aged 20-79) is living with diabetes, with nearly half unaware of their condition. Projections by the IDF suggest that by 2045, one in eight adults approximately 783 million people will have diabetes, marking a 46% increase. This rising prevalence has created an urgent demand for effective tools to monitor and manage blood glucose, driving the need for blood glucose test strips.

The increase in diabetes cases can be attributed to various factors, such as sedentary lifestyles, poor dietary habits, genetic factors, and an aging population. Modern lifestyles, which involve limited physical activity and increased consumption of processed foods, have contributed to higher rates of obesity and insulin resistance both significant risk factors for type 2 diabetes. Additionally, the aging global population further exacerbates the issue, as the likelihood of developing diabetes increases with age. As the number of individuals with diabetes rises, regular blood glucose monitoring becomes increasingly critical for effective disease management.

Blood glucose test strips are vital in this regard, enabling individuals to monitor their blood sugar levels at home or in clinical settings. Real-time monitoring helps patients make informed decisions regarding lifestyle changes, medication adjustments, and overall diabetes management. Growing awareness among healthcare professionals and patients about the importance of continuous glucose monitoring has significantly contributed to the increased adoption of blood glucose test strips.

According to a WHO report in November 2024, diabetes directly caused 1.6 million deaths in 2021, with nearly half of these deaths occurring before the age of 70. Diabetes also contributed to 530,000 kidney disease-related deaths and 11% of cardiovascular deaths. This rising incidence has driven innovation in blood glucose monitoring technologies, with manufacturers investing heavily in research and development to improve the accuracy, efficiency, and user-friendliness of test strips. Technological advancements, such as the integration of smart features and connectivity options, are providing users with a more seamless and convenient experience, meeting the growing demand for reliable glucose monitoring tools and further propelling market expansion.

Growing Awareness and Focus on Diabetes Management

The Global Blood Glucose Test Strips Market is experiencing significant growth, driven by the increased awareness and focus on diabetes management. In recent years, there has been a notable shift towards proactive healthcare, with chronic disease management particularly diabetes emerging as a key priority. Governments, healthcare organizations, and advocacy groups around the world are dedicating more resources to awareness campaigns aimed at educating the public about the risks associated with diabetes and the importance of effective management.

This growing awareness has empowered patients with more knowledge, resulting in a higher demand for tools that enable active participation in diabetes management. Blood glucose test strips are central to this trend, providing individuals with diabetes a reliable means of regularly monitoring their blood sugar levels. Awareness campaigns highlight the benefits of consistent monitoring, emphasizing how it enables individuals to make timely adjustments to their lifestyle, medication, and dietary habits.

For example, in November 2024, Jamaica's Ministry of Health and Wellness launched initiatives focused on diabetes prevention and control. These efforts include public education, early detection, and patient-centered care as part of a broader strategy to combat non-communicable diseases (NCDs) and promote healthier lifestyles. A key component of the initiative is the Jamaica Moves Health Promotion Program, which aims to reduce the prevalence of diabetes, hypertension, and other NCDs by encouraging physical activity, healthy eating, and routine health checkups. The Jamaica Health and Lifestyle Survey has highlighted that four out of 10 people with diabetes are unaware of their condition, making early diagnosis crucial for effective intervention and preventing complications. To address this, healthcare facilities across Jamaica have introduced special days dedicated to diabetes and hypertension management, offering disease education, follow-up care, and patient support.

Healthcare professionals also play a critical role in raising awareness and emphasizing the importance of diabetes management. As the number of diagnosed diabetes cases increases, healthcare providers are increasingly recognizing the importance of regular blood glucose monitoring in achieving optimal patient outcomes. This has led to a stronger emphasis on educating patients about the proper use of blood glucose test strips and incorporating these tools into comprehensive diabetes management plans. Additionally, advancements in blood glucose monitoring technology have further amplified the focus on managing diabetes effectively.

Technological Advancements in Glucose Monitoring Devices

Technological advancements in glucose monitoring devices are playing a pivotal role in boosting the Global Blood Glucose Test Strips Market. Over the years, there has been a remarkable evolution in the field of diabetes management, with a focus on developing more sophisticated and user-friendly monitoring devices. The integration of advanced technology into glucose monitoring devices has not only enhanced the accuracy of blood glucose measurements but has also significantly improved the overall user experience.

One of the key technological advancements is the development of devices that require smaller blood samples. This innovation addresses a common concern among individuals with diabetes, making the testing process less invasive and more comfortable. Smaller sample requirements also contribute to the convenience of testing, encouraging users to monitor their blood glucose levels regularly.

Modern glucose monitoring devices deliver faster results, providing users with real-time information about their blood glucose levels. This rapid turnaround time is critical for individuals with diabetes, enabling them to make immediate adjustments to their treatment plans or lifestyle choices based on the latest readings.

The integration of smart technology into glucose monitoring devices represents a revolutionary shift in the industry. Many devices now come equipped with Bluetooth connectivity, allowing seamless integration with smartphones and other digital platforms. Users can easily transfer their glucose readings to mobile applications for comprehensive data tracking and analysis. This connectivity not only enhances the user experience but also facilitates remote monitoring by healthcare professionals, enabling timely interventions and personalized treatment plans.

Continuous glucose monitoring (CGM) systems are another technological advancement that has gained prominence in the diabetes management landscape. These systems provide real-time glucose readings throughout the day, offering a more comprehensive view of blood glucose patterns. While CGM systems themselves may not use traditional test strips, they contribute to the overall ecosystem of glucose monitoring, influencing user preferences and expectations for accuracy and convenience.

Key Market Challenges

Cost Of Blood Glucose Test Strips

The overall cost of blood glucose test strips stands out as a formidable obstacle hindering the seamless growth of the Global Blood Glucose Test Strips Market. While these strips are indispensable for individuals managing diabetes, their affordability remains a critical concern, impacting accessibility for a significant portion of the global population.

One of the primary factors contributing to the high cost of blood glucose test strips is the intricate technology embedded in their design. Continuous innovation in the field has led to the development of more accurate and user-friendly strips, but these advancements often come at a price. The incorporation of cutting-edge features, such as smaller sample requirements, faster results, and connectivity options, necessitates sophisticated manufacturing processes, materials, and quality control measures, all of which contribute to the overall production cost.

The economic burden of diabetes management is further exacerbated by the need for regular testing. Individuals with diabetes often require multiple tests per day to effectively monitor and manage their blood glucose levels. This frequency of use amplifies the financial strain, especially for those without comprehensive insurance coverage or access to government reimbursement programs. As a result, cost considerations become a significant barrier, potentially leading to reduced compliance with recommended testing frequencies.

Standardization And Regulatory Compliance

Standardization and regulatory compliance emerge as formidable challenges hindering the smooth expansion of the Global Blood Glucose Test Strips Market. The market's growth is intricately tied to the ability to provide reliable, accurate, and consistent blood glucose readings, necessitating adherence to global standards and regulatory frameworks. However, achieving harmonization in testing protocols and regulatory requirements across different regions proves to be a complex task.

One of the primary challenges associated with standardization is the divergence in testing methodologies. Various regions and countries may adopt different standards for evaluating the accuracy and performance of blood glucose test strips. These disparities can lead to confusion among manufacturers, healthcare professionals, and consumers alike, impacting the reliability and consistency of results. Achieving global alignment on standardized testing methodologies is essential for fostering confidence in the accuracy of blood glucose readings and promoting the interoperability of testing systems.

The regulatory landscape further complicates the scenario, with different countries imposing distinct requirements for the approval and commercialization of blood glucose test strips. Regulatory compliance becomes a significant hurdle for manufacturers looking to introduce their products in multiple markets. Navigating the intricate web of regulatory frameworks demands significant resources and time, potentially slowing down the introduction of innovative and improved test strips to consumers.

Key Market Trends

Integration Of Smart Technology into Monitoring Devices

The integration of smart technology into monitoring devices is playing a pivotal role in boosting the Global Blood Glucose Test Strips Market. Modern blood glucose monitoring devices have evolved beyond traditional standalone meters, incorporating intelligent features that leverage connectivity with smartphones and other digital platforms. This integration has transformed the way individuals manage their diabetes, enhancing the overall user experience and providing healthcare professionals with valuable insights.

One of the key advantages of smart technology integration is the seamless transfer of blood glucose readings to mobile applications. Users can easily sync their monitoring devices with smartphones, allowing for real-time data tracking and analysis. This connectivity facilitates comprehensive and immediate access to glucose trends and patterns, empowering individuals to make informed decisions about their diabetes management. The ability to share this data with healthcare professionals also enables remote monitoring, ensuring timely interventions and personalized treatment plans.

The integration of smart features not only enhances the functionality of blood glucose monitoring devices but also contributes to increased user engagement. Smartphone connectivity enables users to receive alerts, reminders, and insights based on their glucose levels, fostering a proactive approach to diabetes management. The interactive and user-friendly interfaces of mobile applications make it easier for individuals to interpret their data, track trends over time, and collaborate with healthcare providers for more effective care.

Moreover, the integration of smart technology into monitoring devices aligns with the broader trend of digital health and the Internet of Things (IoT). This connectivity enables the creation of a connected ecosystem where various health data points can be monitored and analyzed in real-time. The holistic view provided by smart devices enhances the understanding of the relationship between lifestyle factors, medication adherence, and blood glucose levels, contributing to a more comprehensive and personalized approach to diabetes care.

Home-Based Glucose Monitoring

The Global Blood Glucose Test Strips Market is experiencing a substantial boost, thanks to the growing trend of home-based glucose monitoring. This shift in diabetes management has significantly contributed to the increasing demand for blood glucose test strips. Home-based monitoring offers individuals with diabetes the convenience of regularly tracking their blood sugar levels without the need for frequent visits to healthcare facilities. This trend is propelled by the availability of user-friendly blood glucose test strips that empower patients to perform tests in the comfort of their homes.

The convenience of home-based glucose monitoring has reshaped the dynamics of diabetes care. Individuals can easily integrate blood glucose testing into their daily routines, fostering a proactive and consistent approach to managing their condition. The ease of use of modern blood glucose test strips has eliminated many barriers to regular monitoring, encouraging individuals to adhere to recommended testing frequencies. This increased compliance not only supports better diabetes management but also fuels the demand for blood glucose test strips, making them a crucial component of home-based monitoring kits.

Moreover, home-based glucose monitoring aligns with the broader trend of patient-centered care and self-management. Empowering individuals to take an active role in their health is a key goal in modern healthcare, and home-based monitoring achieves this by providing a sense of control and autonomy to those with diabetes. The immediate feedback from blood glucose test strips enables users to make timely adjustments to their treatment plans, lifestyle, and dietary choices, leading to more personalized and effective diabetes management.

The market for blood glucose test strips benefits from the increasing awareness among healthcare professionals and patients about the advantages of home-based monitoring. Healthcare providers are recognizing the value of regular blood glucose monitoring in achieving optimal outcomes for patients. The integration of home-based monitoring into diabetes management plans underscores the importance of blood glucose test strips as essential tools for both patients and healthcare professionals.

Segmental Insights

Type Insights

Based on Type, the Thin Film Electrochemical Films emerged as the fastest growing segment in the global market for Blood Glucose Test Strips during the forecast period. The growth of thin film electrochemical strips can be attributed to their advanced technology, which offers several benefits over traditional blood glucose test strips, including improved accuracy, faster response times, and greater user convenience. These strips are designed to be more cost-effective, efficient, and easier for patients to use, leading to their increasing adoption. The underlying technology of thin film electrochemical strips involves a layer of electrochemical materials that interact with glucose, providing real-time blood glucose readings with enhanced precision. This innovation is driving the demand for more reliable and user-friendly glucose monitoring solutions, especially among diabetic patients who require regular testing. As both healthcare providers and consumers prioritize better diabetes management, these strips are gaining traction due to their ability to deliver accurate results while reducing testing time and minimizing errors. Consequently, manufacturers are investing significantly in research and development to enhance the performance and expand the applications of these strips, further fueling their growth in the global blood glucose test strips market.

End-User Insights

Based on the End-User, Hospitals emerged as the dominant segment in the global market for Global Blood Glucose Test Strips Market in 2024. hospitals are primary healthcare institutions that cater to a diverse patient population, including those with diabetes. The high footfall of patients in hospitals, coupled with the prevalence of diabetes worldwide, results in a substantial demand for blood glucose test strips. Hospitals serve as hubs for diagnostics, treatment, and monitoring of various medical conditions, making them a key consumer of blood glucose monitoring products. hospitals are equipped with comprehensive healthcare infrastructure, including laboratories and specialized departments, which facilitate the efficient use of blood glucose test strips. The presence of trained healthcare professionals, such as nurses and laboratory technicians, ensures proper usage of the test strips and accurate interpretation of results. The centralized nature of hospital settings allows for streamlined and coordinated diabetes management, with blood glucose monitoring being an integral part of routine care.

Regional Insights

Based on Region, North America emerged as the dominant region in the Global Blood Glucose Test Strips Market in 2024. North America, especially the United States, has a significant prevalence of diabetes, driven by factors such as sedentary lifestyles, poor dietary habits, and an aging population. According to the CDC's National Diabetes Statistics Report, 38.4 million Americans of all ages (11.6% of the U.S. population) had diabetes in 2021, with 38.1 million adults (14.7% of all U.S. adults) affected by the condition. This large diabetic population creates a strong demand for blood glucose test strips to effectively monitor and manage the disease.

The healthcare systems in North America, particularly in the U.S. and Canada, are well-established, providing extensive access to healthcare services and advanced technologies. This infrastructure facilitates the widespread use of cutting-edge glucose monitoring devices, including test strips. Additionally, North American countries allocate significant resources toward healthcare, particularly diabetes management and treatment, ensuring that patients have access to the latest technologies in diabetes care, including blood glucose test strips.

There is also a high level of awareness about diabetes management in the region, supported by government initiatives, healthcare providers, and advocacy groups. This educational effort encourages individuals to monitor their blood glucose levels regularly, driving the demand for test strips. Furthermore, the regulatory environment in North America, with agencies like the U.S. FDA, ensures that only safe, high-quality, and effective medical devices, including blood glucose test strips, are available to consumers. This regulatory support enhances consumer confidence and contributes to market growth. These factors along with a strong emphasis on diabetes care position North America as the dominant market for blood glucose test strips globally.

Key Market Players

Abbott Laboratories Inc
F. Hoffmann-La Roche Ltd
LifeScan IP Holdings, LLC
i-SENS, Inc.
Ascensia Diabetes Care Holdings AG
AgaMatrix, Elektronika Sales Pvt Ltd.
Universal Biosensors
TaiDoc Technology Corporation
B. Braun Melsungen AG

Report Scope:

In this report, the Global Blood Glucose Test Strips Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Glucose Test Strips Market, By Type:

Thick Film Electrochemical Films
Thin Film Electrochemical Films
Optical Strips

Blood Glucose Test Strips Market, By End-User:

Hospitals
Ambulatory Surgical Centers
Others

Blood Glucose Test Strips Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Glucose Test Strips Market.

Available Customizations:

Global Blood Glucose Test Strips Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Global Blood Glucose Test Strips Market Outlook

4.1. Market Size & Forecast
- 4.1.1. By Value
4.2. Market Share & Forecast
- 4.2.1. By Type (Thick Film Electrochemical Films, Thin Film Electrochemical Films, Optical Strips)
- 4.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Others)
- 4.2.3. By Region
- 4.2.4. By Company (2024)
4.3. Market Map
- 4.3.1. By Type
- 4.3.2. By End-User
- 4.3.3. By Region

5. Asia Pacific Blood Glucose Test Strips Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.2. By End-User
- 5.2.3. By Country
5.3. Asia Pacific: Country Analysis
- 5.3.1. China Blood Glucose Test Strips Market Outlook
  - 5.3.1.1. Market Size & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share & Forecast
    - 5.3.1.2.1. By Type
    - 5.3.1.2.2. By End-User
- 5.3.2. India Blood Glucose Test Strips Market Outlook
  - 5.3.2.1. Market Size & Forecast
    - 5.3.2.1.1. By Value
  - 5.3.2.2. Market Share & Forecast
    - 5.3.2.2.1. By Type
    - 5.3.2.2.2. By End-User
- 5.3.3. Australia Blood Glucose Test Strips Market Outlook
  - 5.3.3.1. Market Size & Forecast
    - 5.3.3.1.1. By Value
  - 5.3.3.2. Market Share & Forecast
    - 5.3.3.2.1. By Type
    - 5.3.3.2.2. By End-User
- 5.3.4. Japan Blood Glucose Test Strips Market Outlook
  - 5.3.4.1. Market Size & Forecast
    - 5.3.4.1.1. By Value
  - 5.3.4.2. Market Share & Forecast
    - 5.3.4.2.1. By Type
    - 5.3.4.2.2. By End-User
- 5.3.5. South Korea Blood Glucose Test Strips Market Outlook
  - 5.3.5.1. Market Size & Forecast
    - 5.3.5.1.1. By Value
  - 5.3.5.2. Market Share & Forecast
    - 5.3.5.2.1. By Type
    - 5.3.5.2.2. By End-User

6. Europe Blood Glucose Test Strips Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By End-User
- 6.2.3. By Country
6.3. Europe: Country Analysis
- 6.3.1. France Blood Glucose Test Strips Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By End-User
- 6.3.2. Germany Blood Glucose Test Strips Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By End-User
- 6.3.3. Spain Blood Glucose Test Strips Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By End-User
- 6.3.4. Italy Blood Glucose Test Strips Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Type
    - 6.3.4.2.2. By End-User
- 6.3.5. United Kingdom Blood Glucose Test Strips Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Type
    - 6.3.5.2.2. By End-User

7. North America Blood Glucose Test Strips Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By End-User
- 7.2.3. By Country
7.3. North America: Country Analysis
- 7.3.1. United States Blood Glucose Test Strips Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By End-User
- 7.3.2. Mexico Blood Glucose Test Strips Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By End-User
- 7.3.3. Canada Blood Glucose Test Strips Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By End-User

8. South America Blood Glucose Test Strips Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By End-User
- 8.2.3. By Country
8.3. South America: Country Analysis
- 8.3.1. Brazil Blood Glucose Test Strips Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By End-User
- 8.3.2. Argentina Blood Glucose Test Strips Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By End-User
- 8.3.3. Colombia Blood Glucose Test Strips Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By End-User

9. Middle East and Africa Blood Glucose Test Strips Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By End-User
- 9.2.3. By Country
9.3. MEA: Country Analysis
- 9.3.1. South Africa Blood Glucose Test Strips Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By End-User
- 9.3.2. Saudi Arabia Blood Glucose Test Strips Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By End-User
- 9.3.3. UAE Blood Glucose Test Strips Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By End-User
- 9.3.4. Egypt Blood Glucose Test Strips Market Outlook
  - 9.3.4.1. Market Size & Forecast
    - 9.3.4.1.1. By Value
  - 9.3.4.2. Market Share & Forecast
    - 9.3.4.2.1. By Type
    - 9.3.4.2.2. By End-User

10. Market Dynamics

10.1. Drivers
10.2. Challenges

11. Market Trends & Developments

11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions

12. Global Blood Glucose Test Strips Market: SWOT Analysis

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product

14. Competitive Landscape

14.1. Abbott Laboratories Inc.
- 14.1.1. Company Snapshot
- 14.1.2. Products & Services
- 14.1.3. Current Capacity Analysis
- 14.1.4. Financials (In case of listed)
- 14.1.5. Recent Developments
- 14.1.6. SWOT Analysis
14.2. F. Hoffmann-La Roche Ltd
14.3. LifeScan IP Holdings, LLC
14.4. i-SENS, Inc.
14.5. Ascensia Diabetes Care Holdings AG
14.6. AgaMatrix, Elektronika Sales Pvt Ltd.
14.7. Universal Biosensors
14.8. TaiDoc Technology Corporation
14.9. B. Braun Melsungen AG